Doctors at St. Joseph’s/Candler are able to precisely locate and attack potential cancerous nodules with the help of robotic ...

Lung cancer remains one of the most common and deadly cancers worldwide, including in the Middle East, where high smoking rates, air pollution, and other environmental exposures continue to drive new ...

Chemotherapy-free combination regimen ushers in new era for first-line treatment, with overall survival projected to exceed four years, surpassing monotherapy TKI osimertinib by more than one year ...

Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among patients with ROS1-positive non-small cell lung cancer. At the 2025 IASLC World ...

A world-renowned lung cancer expert has belatedly revealed that he was diagnosed with lung cancer three years ago. The decision was made to shift perceptions about lung cancer and inspire courage in ...

INTEGRIS Health did just that, moving him from scan to surgery in only 10 days. Surgeons removed an entire lobe of his lung, ...